https://www.centerforbiosimilars.com/view/administration-for-pegfilgrastim-biosimilars-should-minimize-clinic-visits-consider-patients-preferences
0
0
11/19/22 at 12:07pm
Organization
The Center for Biosimilars
55 words
0
Comments
A review explored the 3 main administration options for pegfilgrastim biosimilars, finding that providers should consider the ease and frequency to which patients will need to travel to a clinic for administration as well as their preferences when choosing a …
You are the first to view
Create an account
or login to join the discussion